EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades

Florien W Boele iD, Patricia W M den Otter, Jaap C Reijneveld iD, Philip C de Witt Hamer iD, Hinke F van Thuijl, Linda M C Lorenz, Pieter Wesseling iD, Frank J Lagerwaard iD, Martin J B Taphoorn iD, Mathilde C M Kouwenhoven iD, Tom J Snijders iD, Linda Douw iD und 1 weitere

Neuro-Oncology · 14.02.2023 · 25 (2) · 351-364

DOI: 10.1093/neuonc/noac185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 01.08.2022. Verfasst von Florien W Boele und 12 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While patients with diffuse low-grade glioma (LGG) often survive for years, there is a risk of tumor progression which may impact patients’ long-term health-related quality of life (HRQOL) and neurocognitive functioning (NCF). We present a follow-up of LGG patients and their informal caregivers (T3) who took part in our previous HRQOL investigations (T1, M = 7 and T2 M = 13 years after diagnosis).

Methods

Participants completed HRQOL (short form-36 health survey [SF-36]; EORTC-BN20), fatigue (Checklist Individual Strength [CIS]), and depression (Center for Epidemiological Studies-Depression [CES-D]) questionnaires and underwent NCF assessments. T3 scores were compared with matched controls. Changes over time (T1–T2–T3) on group and participant level were assessed. Where available, histology of the initial tumor was revised and immunohistochemical staining for IDH1 R132H mutant protein was performed.

Results

Thirty patients and nineteen caregivers participated. Of N = 11 with tissue available, 3 patients had confirmed diffuse LGG. At T3, patients (M = 26 years after diagnosis) had HRQOL and NCF similar to, or better than controls, yet 23.3% and 53.3% scored above the cut-off for depression (≥16 CES-D) and fatigue (≥35 CIS), respectively. Caregivers’ HRQOL was similar to controls but reported high rates of fatigue (63.2%). Over time, patients’ mental health improved (P < .05). Minimal detectable change in HRQOL over time was observed in individual patients (30% improvement; 23.3% decline; 20% both improvement and decline) with 23.3% remaining stable. NCF remained stable or improved in 82.8% of patients.

Conclusions

While HRQOL and NCF do not appear greatly impacted during long-term survivorship in LGG, depressive symptoms and fatigue are persistent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaHumansCaregiversQuality of LifeLongitudinal StudiesFatigueSurveys and Questionnaires

Stichwörter der Autor:innen

depressionfatiguelow-grade gliomaquality of lifesurvivorship

Autor:innen und Institutionen

  • Leeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.
  • Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
  • Department of Medical Psychology, Cancer Center Amsterdam, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Department of Neurology, SEIN, Heemstede, the Netherlands.
  • Department of Neurology, Cancer Center Amsterdam, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.
  • Department of Neurosurgery, Cancer Center Amsterdam, Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Florien W Boele, Jaap C Reijneveld, Philip C de Witt Hamer, Pieter Wesseling, Frank J Lagerwaard, Martin J B Taphoorn, Mathilde C M Kouwenhoven, Tom J Snijders, Linda Douw, Martin Klein

Zitieren

APA

Boele, F. W., den Otter, P. W. M., Reijneveld, J. C., de Witt Hamer, P. C., van Thuijl, H. F., Lorenz, L. M. C., Wesseling, P., Lagerwaard, F. J., Taphoorn, M. J. B., Kouwenhoven, M. C. M., Snijders, T. J., Douw, L., & Klein, M. (2023). Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades. Neuro-Oncology, 25(2), 351-364. https://doi.org/10.1093/neuonc/noac185

Vancouver

Boele FW, den Otter PWM, Reijneveld JC, de Witt Hamer PC, van Thuijl HF, Lorenz LMC, et al. Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades. Neuro-Oncology. 2023;25(2):351-364. doi:10.1093/neuonc/noac185

BibTeX
@article{Boele2023,
  author = {Boele, Florien W and den Otter, Patricia W M and Reijneveld, Jaap C and de Witt Hamer, Philip C and van Thuijl, Hinke F and Lorenz, Linda M C and Wesseling, Pieter and Lagerwaard, Frank J and Taphoorn, Martin J B and Kouwenhoven, Mathilde C M and Snijders, Tom J and Douw, Linda and Klein, Martin},
  title = {Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades},
  journal = {Neuro-Oncology},
  year = {2023},
  volume = {25},
  number = {2},
  pages = {351--364},
  doi = {10.1093/neuonc/noac185}
}
Kostenlos starten →